BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7182530)

  • 21. [Clinical effects of cefoxitin on infections in digestive diseases].
    Irie T; Sakai H; Mae S
    Jpn J Antibiot; 1985 Jan; 38(1):74-82. PubMed ID: 3989980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical use of cefoxitin in respiratory tract infections].
    Niki Y; Yoshida N; Hara H; Soejima R
    Jpn J Antibiot; 1984 Jan; 37(1):97-103. PubMed ID: 6727034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical studies of cefoxitin in the pediatric field (author's transl)].
    Kida K; Watanabe N; Matsuda H; Murase M
    Jpn J Antibiot; 1981 Mar; 34(3):367-73. PubMed ID: 7289029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrent infections in hematologic diseases treated with cefoxitine (author's transl)].
    Bauters F; Jouet JP
    Sem Hop; 1980 Dec 8-15; 56(45-46):1963-7. PubMed ID: 6256908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies of cefoxitin for the treatment of septicemia (author's transl)].
    Yoshida S; Katsurada K; Matsuoka K
    Jpn J Antibiot; 1981 Sep; 34(9):1299-306. PubMed ID: 7328752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies of cefoxitin with special reference to pulmonary suppuration and pyothorax with respiratory tract infection].
    Ito T
    Jpn J Antibiot; 1984 Sep; 37(9):1679-84. PubMed ID: 6512984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of cefoxitin, a new semisynthetic cephamycin.
    Little PJ; Peddie BA
    N Z Med J; 1978 Jul; 88(616):46-9. PubMed ID: 279853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on cefoxitin in the field of gastro-surgery (author's transl)].
    Suzuki H; Kurose T; Nagao J; Sumiyama Y; Onda M; Tsurumi K
    Jpn J Antibiot; 1981 Nov; 34(11):1447-50. PubMed ID: 7334578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies on cefoxitin in the prevention of postoperative infections and the treatment of postoperative pulmonary and urinary tract infections].
    Sakaki T; Morimoto T; Hori Y; Takemura K; Masuda A
    Jpn J Antibiot; 1985 Jun; 38(6):1625-37. PubMed ID: 4046178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experience with cefoxitin used for the prevention of postoperative infections].
    Kato F; Miyazaki T; Itoh K; Okamura H; Tohga S
    Jpn J Antibiot; 1982 Aug; 35(8):1993-7. PubMed ID: 7154247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical findings of cefoxitin in the treatment of obstetric and gynecological infections (author's transl)].
    Hayasaki M; Iwasa SU; Noda K; Yamada Y; Ito K; Iida M; Chin C
    Jpn J Antibiot; 1982 Jan; 35(1):189-201. PubMed ID: 7069930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies of cefoxitin in the field of internal medicine].
    Ito A; Shindo K; Sakamoto H; Sano F; Ishigatsubo Y; Matsumura M; Tani K; Maruta I; Kodama F; Fukushima K
    Jpn J Antibiot; 1983 Jan; 36(1):84-92. PubMed ID: 6842829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacteriological and clinical evaluation of cefoxitin in the treatment of infections in 39 obstetric and gynecological patients].
    Kaseki S; Mano T; Tomoda Y; Kazato S; Asai Y; Sahara K; Manba S; Maruyama T; Kasugai M; Higashide K; Sekiya H; Mizutani S; Watanabe K; Ueno K
    Jpn J Antibiot; 1983 Mar; 36(3):509-21. PubMed ID: 6876361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical studies on cefoxitin in the treatment of respiratory tract infections].
    Kuwabara M; Kodomari Y; Jyo T; Kuraoka T; Mitsuyama T; Kodomari N; Iwamoto K; Miyazawa T; Watanabe T; Morikawa E
    Jpn J Antibiot; 1984 Sep; 37(9):1685-93. PubMed ID: 6512985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of cefoxitin in chronic respiratory tract infections: evaluation in poorly responding cases to other antibiotics (author's transl)].
    Hiraga Y; Abe M; Kikuchi K; Nakahashi M
    Jpn J Antibiot; 1980 Oct; 33(10):1111-24. PubMed ID: 7206215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical findings of cefoxitin in the treatment of serious infections and the prevention of postoperative infections (author's transl)].
    Ito H; Uno E; Ikeda M; Shimoji T; Higashi S; Yamamoto S
    Jpn J Antibiot; 1981 Sep; 34(9):1307-12. PubMed ID: 7328753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study on micronomicin in the field of internal medicine].
    Komatsu Y; Kakizaki R; Tsushima K; Sakata Y
    Jpn J Antibiot; 1983 Mar; 36(3):529-36. PubMed ID: 6876362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experience with cefoxitin in pediatric field (author's transl)].
    Okamoto T; Ohara K; Tomimatsu H; Hosoda T
    Jpn J Antibiot; 1981 Mar; 34(3):352-8. PubMed ID: 7289027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of cefuzonam of severe infections in leukemia and related disorders].
    Tsuda S; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Kashima K; Yashige H; Fujii H
    Jpn J Antibiot; 1990 Aug; 43(8):1381-91. PubMed ID: 2283706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.